Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Company Information

Company Information

SENORES PHARMACEUTICALS LTD.

NSE : SENORESBSE : 544319ISIN CODE : INE0RB801010Industry : Pharmaceuticals & DrugsHouse : Private
BSE772.2018.5 (+2.45 %)
PREV CLOSE ( ) 753.70
OPEN PRICE ( ) 740.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11333
TODAY'S LOW / HIGH ( )739.70 785.35
52 WK LOW / HIGH ( )440 832
ChairmanSanjay Shaileshbhai Majmudar
Managing DirectorSwapnil Jatinbhai Shah
Company SecretaryVinay Kumar Mishra
Non Executive Independent DirectorNaresh Bansilal Shah
Manjula Devi Shroff
Kalpit Rajesh Gandhi
Udayan Dileep Choksi
Whole Time DirectorChetan Bipinchandra Shah
Deval Rajnikant Shah
Non Independent & Non Executive DirectorHemanshu Nitinchandra Pandya
Jitendra Babulal Sanghvi
Ashokkumar Vijaysinh Barot
Arpit Deepakkumar Shah
Incorporation Year : 26-12 2017

Registered Office :

Address : 1101 To 1103, 11th Floor, South Tower,One 42 Opp. Jayantilal Park,Ambali Bopal Road Ahmedabad,
Gujarat-380054 .

Phone : 079-29999857

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.